๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
The primary objective is to assess the safety and tolerability of TAB004 as...
Status
Unknown
Location
University of Alabama at Birmingham
Start Date
2019-10-30
Trial ID
NCT04137900
Treatments Being Tested
This study will investigate if Toripalimab (A PD-1 Inhibitor) will improve ...
Status
Active Not Recruiting
Location
Zhongshan Hospital,Fudan University
Start Date
2019-03-05
Trial ID
NCT03859128
Treatments Being Tested
Purpose: This phase II clinical trial evaluates whether a combination of li...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-30
Trial ID
NCT07685535
Treatments Being Tested
Toripalimab is a programmed cell death protein 1 antibody.This is an open-l...
Status
Unknown
Location
Zhongshan Hospital
Start Date
2019-08-01
Trial ID
NCT04926532
Treatments Being Tested
The goal of this clinical trial is to learn if the drug toripalimab (an ant...
Status
Active Not Recruiting
Location
Changyi Quan
Start Date
2022-10-10
Trial ID
NCT06584435
Treatments Being Tested
A Phase โ ก, open-label, single-arm study to assess the safety, tolerability,...
Status
Unknown
Location
The Affiliated Hospital of Xuzhou Medical University
Start Date
2021-09-01
Trial ID
NCT05056116
Treatments Being Tested
The combination of immune checkpoint inhibitors (ICIs) and tyrosine kinase ...
Status
Recruiting
Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Start Date
2026-06-01
Trial ID
NCT07611825
Treatments Being Tested
To evaluate the anti-tumor activity, safety and tolerance of toripalimab as...
Status
Unknown
Location
Cancer center of Sun Yat-sen University
Start Date
2018-11-21
Trial ID
NCT03811379
Treatments Being Tested
The primary objective is to assess the safety and tolerability of JS-001 in...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Science
Start Date
2016-08
Trial ID
NCT02836834
Treatments Being Tested